Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI

NCT05826366 · clinicaltrials.gov ↗

COMPLETED

Status

296

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Sponsor

AstraZeneca